With this consideration in mind, favorable effects of CLDN7 on adiponectin levels have been identified, along with a positive impact on AT function after an intense lifestyle intervention in patients living with overweight/obesity [97] (Figure 4). The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.